NCT04388215 - Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions

HypertensionDyslipidemias

Interventions

DRUG

CKD-828

orally, 1 tablet once a day for 8 weeks

DRUG

CKD-828(placebo)

orally, 1 tablet once a day for 8 weeks

DRUG

D326

orally, 1 tablet once a day for 8 weeks

DRUG

D326(placebo)

orally, 1 tablet once a day for 8 weeks

DRUG

D337

orally, 1 tablet once a day for 8 weeks

DRUG

D337(placebo)

orally, 1 tablet once a day for 8 weeks

DRUG

D013

orally, 1 tablet once a day for 8 weeks

DRUG

D013(placebo)

orally, 1 tablet once a day for 8 weeks

Trial Locations (1)

RECRUITING

Korea University Guro Hospital, Seoul